Paul Blundell

677 total citations
20 papers, 554 citations indexed

About

Paul Blundell is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Blundell has authored 20 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Blundell's work include Neuroscience and Neuropharmacology Research (9 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Receptor Mechanisms and Signaling (7 papers). Paul Blundell is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Receptor Mechanisms and Signaling (7 papers). Paul Blundell collaborates with scholars based in United States. Paul Blundell's co-authors include Peter C. Meltzer, Bertha K. Madras, Mario D. González, D. H. R. BARTON, Joseph Cs. Jászberényi, Clifford George, Zhengming Chen, Alun G. Jones, Basem Garada and R.E. Zimmerman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Paul Blundell

20 papers receiving 542 citations

Peers

Paul Blundell
Daniel J. Canney United States
Michael A. Kuzemko United States
M. Abdur Rahman United States
Sumalee Chumpradit United States
F. Moureau Belgium
Daniel J. Canney United States
Paul Blundell
Citations per year, relative to Paul Blundell Paul Blundell (= 1×) peers Daniel J. Canney

Countries citing papers authored by Paul Blundell

Since Specialization
Citations

This map shows the geographic impact of Paul Blundell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Blundell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Blundell more than expected).

Fields of papers citing papers by Paul Blundell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Blundell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Blundell. The network helps show where Paul Blundell may publish in the future.

Co-authorship network of co-authors of Paul Blundell

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Blundell. A scholar is included among the top collaborators of Paul Blundell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Blundell. Paul Blundell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meltzer, Peter C., Paul Blundell, Ali A. Bonab, et al.. (2003). A Second-Generation 99mTechnetium Single Photon Emission Computed Tomography Agent That Provides in Vivo Images of the Dopamine Transporter in Primate Brain. Journal of Medicinal Chemistry. 46(16). 3483–3496. 10 indexed citations
2.
Meltzer, Peter C., et al.. (2003). Synthesis and Evaluation of Dopamine and Serotonin Transporter Inhibition by Oxacyclic and Carbacyclic Analogues of Methylphenidate. Journal of Medicinal Chemistry. 46(8). 1538–1545. 33 indexed citations
3.
Lovey, Raymond G., Anil K. Saksena, Viyyoor Girijavallabhan, et al.. (2002). Synthesis and antifungal activity of the 2,2,5-tetrahydrofuran regioisomers of SCH 51048. Bioorganic & Medicinal Chemistry Letters. 12(13). 1739–1742. 9 indexed citations
4.
Meltzer, Peter C., et al.. (2002). Design and synthesis of an irreversible dopamine-sparing cocaine antagonist. Bioorganic & Medicinal Chemistry. 10(11). 3583–3591. 18 indexed citations
5.
Meltzer, Peter C., Bing Wang, Zhengming Chen, et al.. (2001). Synthesis of 6- and 7- Hydroxy-8-azabicyclo[3.2.1]octanes and Their Binding Affinity for the Dopamine and Serotonin Transporters. Journal of Medicinal Chemistry. 44(16). 2619–2635. 38 indexed citations
6.
Meltzer, Peter C., et al.. (2000). 3-Aryl-2-carbomethoxybicyclo[3.2.1]oct-2-enes inhibit WIN 35,428 binding potently and selectively at the dopamine transporter. Bioorganic & Medicinal Chemistry. 8(3). 581–590. 22 indexed citations
7.
Meltzer, Peter C., Paul Blundell, Zhengming Chen, et al.. (2000). 2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes:  Potent Non-Nitrogen Inhibitors of Monoamine Transporters. Journal of Medicinal Chemistry. 43(16). 2982–2991. 52 indexed citations
8.
Meltzer, Peter C., et al.. (1999). Bicyclo[3.2.1]octanes: Synthesis and inhibition of binding at the dopamine and serotonin transporters. Bioorganic & Medicinal Chemistry Letters. 9(6). 857–862. 27 indexed citations
9.
Meltzer, Peter C., Paul Blundell, Mario D. González, et al.. (1997). 2-Carbomethoxy-3-aryl-8-oxabicyclo[3.2.1]octanes:  Potent Non-Nitrogen Inhibitors of Monoamine Transporters. Journal of Medicinal Chemistry. 40(17). 2661–2673. 64 indexed citations
10.
Chen, Zhengming, Mario D. González, Paul Blundell, & Peter C. Meltzer. (1997). A ring opening rearrangement reaction of 6β-hydroxytropinone. Tetrahedron Letters. 38(39). 6823–6824. 1 indexed citations
11.
Meltzer, Peter C., Paul Blundell, Alun G. Jones, et al.. (1997). A Technetium-99m SPECT Imaging Agent Which Targets the Dopamine Transporter in Primate Brain. Journal of Medicinal Chemistry. 40(12). 1835–1844. 46 indexed citations
12.
Madras, Bertha K., Zdenek B. Pristupa, Hyman B. Niznik, et al.. (1996). Nitrogen-based drugs are not essential for blockade of monoamine transporters. Synapse. 24(4). 340–348. 54 indexed citations
13.
Madras, Bertha K., Alun G. Jones, Ashfaq Mahmood, et al.. (1996). Technepine: A high-affinity99mtechnetium probe to label the dopamine transporter in brain by SPECT imaging. Synapse. 22(3). 239–246. 53 indexed citations
14.
Madras, Bertha K., et al.. (1996). Nitrogen‐based drugs are not essential for blockade of monoamine transporters. Synapse. 24(4). 340–348. 2 indexed citations
15.
Blundell, Paul, Ashit K. Ganguly, & Viyyoor Girijavallabhan. (1994). Synthesis of Novel Azole Antifungals by a Modified Sharpless Asymmetric Dihydroxylation. Synlett. 1994(4). 263–265. 21 indexed citations
16.
BARTON, D. H. R., Paul Blundell, & Joseph Cs. Jászberényi. (1992). The invention of radical reactions. Part XXVIII a new very photolabile O-acyl thiohydroxamic acid derivative as precursor of carbon radicals. Tetrahedron. 48(35). 7121–7130. 4 indexed citations
17.
BARTON, D. H. R., Paul Blundell, & Joseph Cs. Jászberényi. (1991). Quantum yields in the photochemically induced radical chemistry of acyl derivatives of thiohydroxamic acids. Journal of the American Chemical Society. 113(18). 6937–6942. 28 indexed citations
18.
BARTON, D. H. R., Paul Blundell, & Joseph Cs. Jászberényi. (1991). ChemInform Abstract: Quantum Yields in the Photochemically Induced Radical Chemistry of Acyl Derivatives of Thiohydroxamic Acids.. ChemInform. 22(50). 1 indexed citations
19.
BARTON, D. H. R., et al.. (1991). The invention of radical reactions. Part XXI. Simple methods for the radical deoxygenation of primary alcohols.. Tetrahedron. 47(43). 8969–8984. 45 indexed citations
20.
BARTON, D. H. R., Paul Blundell, & Joseph Cs. Jászberényi. (1989). Acyl derivatives of hydroxamic acids as a source of carbon radicals. Tetrahedron Letters. 30(18). 2341–2344. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026